schizophrenia

News and resources

Nov 14 2024

Psychedelics Like Psilocybin, MDMA Tied to Higher Odds for Schizophrenia

by Clinical Editor

No Comments

Even after controlling for a person’s existing substance use and mental health disorders, there remained a 3.5-fold increased risk of schizophrenia after ER treatment for psychedelics use. Hallucinogens include drugs...

Nov 14 2024

Uncategorized

Despite setback, AbbVie’s big bet on neuroscience has yet to play out

by Clinical Editor

No Comments

For AbbVie, the failure of a high-profile schizophrenia drug hardly marks its last chance to invest in neuroscience. But the effort might not get any easier.

Nov 13 2024

Uncategorized

AbbVie’s Schizophrenia Failure Disappoints But Analysts Show Confidence In Immunology Portfolio

by Clinical Editor

No Comments

AbbVie stock drops after emraclidine fails Phase 2 trials for schizophrenia, raising questions about its neuroscience strategy and boosting competition for Cobenfy.

Nov 13 2024

Uncategorized

Glial Cells May Influence Depression and Schizophrenia

by Clinical Editor

No Comments

New research highlights neuroglia (or glia cells) as critical players in mental health, potentially influencing conditions like depression and schizophrenia.

Nov 12 2024

Uncategorized

Magnetic Stimulation Reduced Auditory Hallucinations in Patients With Schizophrenia

by Clinical Editor

No Comments

For patients with schizophrenia, repetitive transcranial magnetic stimulation (rTMS) was effective and safe in treating auditory verbal hallucinations, according to a randomized sham-controlled trial.

Nov 12 2024

Uncategorized

Family member says man shot by Indianapolis officer has schizophrenia

by Clinical Editor

No Comments

According to court documents, an Indianapolis Metropolitan Police sergeant interviewed Hill’s father who called 911 just after Hill approached the woman to alert police that his son suffered from schizophrenia...

Nov 11 2024

Uncategorized